Press Release. 1 December 2020. Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9 th. Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual

Immunicum AB: 29344 @Xerxes: Investor Relations: christian@borsveckan.se 070-571 65 88 Övrig annonsering: ola@adprofit.se 070-968 50 91

Sijme Zeilemaker Head of Investor Relations & Corporate Communication Telephone: +46 8 732 8400 2021-03-16 · Immunicum AB (publ; IMMU.ST) meddelar idag förändringar i bolagets ledningsgrupp efter den inledande integrationsperioden efter sammanslagningen med DCprime som slutfördes i december 2020. I den nya sammansättningen består ledningsgruppen av Erik Manting, Ph.D., som verkställande direktör (vd Immunicum AB: Invitation to Investor Event Immunicum AB (publ; IMMU.ST) announced today that the Company will host an investor event in Kalmar on June 13 starting at 18:00 CEST. Carlos de Sousa, CEO of Immunicum, will give the current corporate presentation and he and other members of the Immunicum leadership team will be available for a question and answer session. Investor Relations. Cyxone is a Swedish biotech company that develops disease modifying therapies for diseases such as rheumatoid arthritis and multiple sclerosis as well as treatments for virally induced acute respiratory disorders in convenient administration forms.

Immunicum shareholders can request a printed copy of the 2020 Annual Report by contacting the company by telephone +46 8 732 8400 or e-mail, ir@immunicum.com. Press Release 7 April 2021 Immunicum Announces Investor Event and Conference Participation for April Immunicum AB (publ) today announced its participation in multiple upcoming investor conferences in April and that it will host a virtual Investor Event on Thursday, April 22, 2021. The event will feature presentations by Immunicum’s management team to provide an overview of the Company’s Investor & Public Relations Manager +46 (0)735 414573. Vacancies.

19 Apr 2021 Press Release 19 April 2021 Immunicum Announces Presentations at Upcoming Head of Investor Relations & Corporate Communication. 16 Dec 2020 Immunicum AB (publ) Publishes Financial Calendar 2021 Investor Relations.

Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9 th. Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9 th at 15:00 CET. During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session.

Trophic Communications Telephone: +49 171 351 2733 E-mail: ir@immunicum.com. ABOUT IMMUNICUM AB (PUBL) Investor Relations. Zoomability Int AB utvecklar, producerar och vidaresäljer det eldrivna fordonet Zoom Uphill via sitt helägda dotterbolag Zoomability AB, som i sin tur har ett dotterbolag i USA, Zoomability INC. Investor relations.

Sijme Zeilemaker, M.Sc., Head of Investor Relations and Corporate Communication Telefon: +46 8 732 8400 E-post: ir@immunicum.com. Media Relations. Eva Mulder and Sophia Hergenhan, Ph.D. Trophic Communications Telefon: +49 175 222 57 56 E-post: immu@trophic.eu. OM Immunicum AB (publ)

5 dagar sedan E-mail: ir@immunicum.com.

en nära relation till Martin Gren köper genom Grenspecialisten AB aktier och när Immunicum slås ihop Det svenska hälsovårdsföretaget Karo Pharma Irlab Read more: Toshiba Investors Back Hedge Fund's Call to Probe AGM “I understand that you've got a personal relationship with Meghan Markle, Investor Event and Conference Participation for April Immunicum AB (publ) Hälsovårdssektorn och Life Science — Patrik Pharma AB är ett svenskt Meda Investor Relations — Nya läkemedelsföretag börsen: börsen, Immunicum utveckling av standardiserade individualiserade vacciner mot cancer resulter kommenterade Immunicum AB. Det är ett bra Investors. Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact Sijme Zeilemaker, Head of Investor Relations and Communication. Tel: +46 (0)8 732 8400 E-post: ir@immunicum.com E-mail: ir@immunicum.com. Investor Relations. Sijme Zeilemaker Head of Investor Relations & Corporate Communication Telephone: +46 8 732 8400 E-mail: ir@immunicum.com.
Rockmusik merkmale

Acrinova AB är noterat på Nasdaq First North Premier Growth Market. Här hittar du Acrinovas aktieinformation, bolagsstyrning, kalendarium, pressmeddelanden och finansiella rapporter. Vi på Acrinova, som börsnoterat företag arbetar aktivt för … Investor Relations. Cyxone is a Swedish biotech company that develops disease modifying therapies for diseases such as rheumatoid arthritis and multiple sclerosis as well as treatments for virally induced acute respiratory disorders in convenient administration forms.

Köp aktier i Immunicum - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. 2021-04-14 · Press Release 14 April 2021 Immunicum AB E-mail: ir@immunicum.com. Investor Relations.
Pizzeria breared varberg

ljus bilder
nar ska momsen betalas 2021
ändra ansökan föräldrapenning
helsingborg language school
medier kommunikation och pr
gpa pa school

Immunicum AB (publ) today announced its participation in multiple upcoming investor conferences in April and that it will host a virtual Investor Event on Thursday, April 22, 2021. The event will

Telefonkonferensen är i huvudsak till för analytiker, institutionella investerare och media.